Articles from Y-Prime, LLC

YPrime’s Karl McEvoy Appointed as eCOA Consortium Industry Co-Director for 2025
Recognition Highlights YPrime's Commitment to Patient-Focused eCOA Innovation
By Y-Prime, LLC · Via GlobeNewswire · January 14, 2025
YPrime Survey Finds 62% of Clinical Site Staff Report eCOA Platforms are Misaligned with Site Needs
New YPrime report offers guidance to sponsors on enhancing site and patient technology experience to increase overall trial efficiency
By Y-Prime, LLC · Via GlobeNewswire · September 25, 2024
YPrime Recognized as Trailblazer in Patient Engagement by Everest Group
Prestigious Distinction Highlights YPrime's Innovative Approach to Enhancing Clinical Trial Participation with Industry-Leading eCOA
By Y-Prime, LLC · Via GlobeNewswire · September 24, 2024
YPrime Launches Breakthrough eCOA Platform to Deliver Up to 30% Faster Implementations
YPrime’s eCOA Now Offers Unmatched 100% Configurability and User-Centric Design—Enabling Faster Study Startup, High-Quality Data, and Operational Efficiencies
By Y-Prime, LLC · Via GlobeNewswire · July 24, 2024
YPrime Research Reveals User-Centric eCOA Technologies as Key to Overcoming Challenges in Endocrinology Clinical Trials
New Findings Highlight the Importance of Therapeutic Area-Specific Solutions and Collaborative Approaches in Advancing Endocrinology Research
By Y-Prime, LLC · Via GlobeNewswire · June 25, 2024
YPrime Transforms Endocrinology and Autoimmune Trials through New Glucometer and eCOA Integrated Functionality
Developed in Partnership with Patients, New Solution Enhances Data Quality, Patient Compliance, and Diary Adherence
By Y-Prime, LLC · Via GlobeNewswire · May 21, 2024
YPrime Appoints Lindsay Daniel as Chief Human Resources Officer
Seasoned HR Executive Joins YPrime to Align People Strategy with Business Priorities and Strengthen Culture
By Y-Prime, LLC · Via GlobeNewswire · May 14, 2024
New YPrime Report Highlights eCOA's Impact on CNS Trials
Collaborative research with clinical trial professionals identifies ways eCOA can contribute to faster neurological breakthroughs
By Y-Prime, LLC · Via GlobeNewswire · May 1, 2024
YPrime Launches Intuitive Tender Swollen Joint Count (TSJC) Assessment for Effortless eCOA
New assessment enables faster, more accurate, and user-friendly data collection to accelerate clinical research
By Y-Prime, LLC · Via GlobeNewswire · April 30, 2024
YPrime Survey Reveals Challenges and Opportunities for Streamlining Oncology Trials with eCOA
Survey explores how eCOA enhances patient experience and reduces risk and uncertainty
By Y-Prime, LLC · Via GlobeNewswire · April 3, 2024
YPrime's Latest Research Reveals Significant Impact of eCOA Platform Delays on Clinical Trial Efficiency
Poor operational efficiency driving the need to increase start-up and protocol amendment implementation speed
By Y-Prime, LLC · Via GlobeNewswire · January 30, 2024
YPrime Unveils a Transformative Brand Focused on Solving for Certainty in Clinical Trials
Clinical trial technology leader amplifies its dedication to empowering researchers and revolutionizing the clinical trial landscape
By Y-Prime, LLC · Via GlobeNewswire · January 22, 2024